INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,086,000 | +9.9% | 10,000 | +66.7% | 0.02% | -4.8% |
| Q3 2016 | $988,000 | -22.2% | 6,000 | -32.6% | 0.02% | -32.3% |
| Q2 2016 | $1,270,000 | +295.6% | 8,900 | +256.0% | 0.03% | +210.0% |
| Q1 2016 | $321,000 | +2.2% | 2,500 | +19.0% | 0.01% | +25.0% |
| Q4 2015 | $314,000 | -14.0% | 2,100 | -4.5% | 0.01% | -20.0% |
| Q3 2015 | $365,000 | +37.2% | 2,200 | +100.0% | 0.01% | +42.9% |
| Q2 2015 | $266,000 | -49.2% | 1,100 | -40.8% | 0.01% | -36.4% |
| Q1 2015 | $524,000 | -13.8% | 1,858 | -52.4% | 0.01% | 0.0% |
| Q4 2014 | $608,000 | +83.7% | 3,900 | +178.6% | 0.01% | +83.3% |
| Q3 2014 | $331,000 | -94.2% | 1,400 | -94.2% | 0.01% | -94.0% |
| Q2 2014 | $5,713,000 | +610.6% | 24,144 | +891.1% | 0.10% | +566.7% |
| Q1 2014 | $804,000 | – | 2,436 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |